Get the Stockscreener App
2.81
2.77%
-0.08
Pre-market:
2.80
-0.01
-0.36%
Maravai Lifesciences Holdings Inc stock is traded at $2.81, with a volume of 1.61M.
It is down -2.77% in the last 24 hours and up +7.66% over the past month.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
See More
Previous Close:
$2.89
Open:
$2.91
24h Volume:
1.61M
Relative Volume:
1.06
Market Cap:
$406.54M
Revenue:
$288.95M
Net Income/Loss:
$-119.03M
P/E Ratio:
-3.1205
EPS:
-0.9005
Net Cash Flow:
$60.67M
1W Performance:
+8.08%
1M Performance:
+7.66%
6M Performance:
+6.44%
1Y Performance:
-69.59%
1-Day Range:
$2.79
$2.975
1-Week Range:
$2.60
$2.975
52-Week Range:
$1.665
$9.50
Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile
Name
Maravai Lifesciences Holdings Inc
Sector
Industry
Phone
(858) 546-0004
Address
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
Compare MRVI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRVI
Maravai Lifesciences Holdings Inc
|
2.81 | 418.12M | 288.95M | -119.03M | 60.67M | -0.9005 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.15 | 100.34B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
585.50 | 60.95B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.73 | 60.46B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
734.35 | 46.04B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.20 | 36.02B | 3.81B | -644.79M | -669.77M | -6.24 |
Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-26-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Dec-19-24 | Initiated | Guggenheim | Neutral |
| Dec-05-24 | Downgrade | Goldman | Neutral → Sell |
| Nov-14-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-08-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Aug-13-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-10-24 | Initiated | Craig Hallum | Buy |
| Dec-12-23 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-08-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| May-23-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| May-09-23 | Downgrade | Goldman | Buy → Neutral |
| Jan-05-23 | Downgrade | UBS | Buy → Neutral |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Nov-03-22 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Dec-16-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Dec-15-20 | Initiated | BofA Securities | Buy |
| Dec-15-20 | Initiated | Credit Suisse | Outperform |
| Dec-15-20 | Initiated | Goldman | Buy |
| Dec-15-20 | Initiated | Jefferies | Buy |
| Dec-15-20 | Initiated | Robert W. Baird | Outperform |
| Dec-15-20 | Initiated | Stifel | Buy |
| Dec-15-20 | Initiated | William Blair | Outperform |
| Dec-14-20 | Initiated | UBS | Buy |
View All
Maravai Lifesciences Holdings Inc Stock (MRVI) Latest News
Using data models to predict Maravai LifeSciences Holdings Inc. stock movementBuy Signal & Fast Entry Momentum Alerts - newser.com
How to build a custom watchlist for Maravai LifeSciences Holdings Inc.2025 Big Picture & Advanced Swing Trade Entry Plans - newser.com
Real time scanner hits for Maravai LifeSciences Holdings Inc. explainedWeekly Stock Analysis & Free Community Supported Trade Ideas - newser.com
Maravai LifeSciences (NASDAQ:MRVI) Trading Down 3.8%Time to Sell? - MarketBeat
What is the target price for Maravai LifeSciences Holdings Inc stock2025 Trade Ideas & AI Forecast Swing Trade Picks - خودرو بانک
Key resistance and support levels for Maravai LifeSciences Holdings Inc.July 2025 Price Swings & Verified Momentum Stock Alerts - newser.com
Will Maravai LifeSciences Holdings Inc. rebound enough to break evenMarket Weekly Review & Daily Entry Point Alerts - newser.com
Jacobs Levy Equity Management Inc. Acquires 401,673 Shares of Maravai LifeSciences Holdings, Inc. $MRVI - MarketBeat
Real time alert setup for Maravai LifeSciences Holdings Inc. performance - newser.com
Is Maravai LifeSciences Holdings Inc. showing signs of accumulation2025 Investor Takeaways & Weekly High Momentum Picks - newser.com
Aug Fed Impact: Can Maravai LifeSciences Holdings Inc. ride the EV waveWeekly Investment Report & AI Driven Stock Movement Reports - خودرو بانک
Can machine learning forecast Maravai LifeSciences Holdings Inc. recoveryTrade Analysis Report & Risk Managed Investment Signals - newser.com
Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Wells Fargo Reiterates a Buy Rating on Maravai LifeSciences Holdings (MRVI) - MSN
Is now a turning point for Maravai LifeSciences Holdings Inc.2025 Buyback Activity & Expert Approved Trade Ideas - newser.com
Ranking Maravai LifeSciences Holdings Inc. among high performing stocks via toolsWeekly Market Outlook & Technical Confirmation Trade Alerts - newser.com
Aug Catalysts: What is the target price for Maravai LifeSciences Holdings Inc. stock2025 Trade Ideas & Smart Money Movement Tracker - خودرو بانک
Why Maravai LifeSciences Holdings Inc. is moving today2025 Investor Takeaways & Growth Focused Stock Pick Reports - newser.com
CEO Moves: What are Maravai LifeSciences Holdings Incs earnings expectationsDip Buying & Weekly High Return Stock Forecasts - خودرو بانک
Volume Recap: Can Maravai LifeSciences Holdings Inc outperform in the next rallyJuly 2025 Analyst Calls & Fast Entry and Exit Trade Plans - خودرو بانک
Aug EndMonth: Is Maravai LifeSciences Holdings Inc.’s ROIC above industry averageJuly 2025 Pullbacks & Consistent Return Investment Signals - خودرو بانک
What’s next for Maravai LifeSciences Holdings Inc. stock priceEarnings Overview Summary & Accurate Buy Signal Notifications - newser.com
Aug Action: Can Maravai LifeSciences Holdings Inc. outperform in the next rally - خودرو بانک
Highs Report: What is the dividend yield of Maravai LifeSciences Holdings Inc2025 Winners & Losers & Fast Moving Trade Plans - خودرو بانک
Will Maravai LifeSciences Holdings Inc. stock go up soonJuly 2025 Big Picture & Safe Entry Momentum Stock Tips - newser.com
Published on: 2025-09-15 14:03:50 - newser.com
Maravai LifeSciences Holdings Inc. recovery potential after sell off2025 Technical Overview & Real-Time Buy Signal Alerts - newser.com
134,089 Shares in Maravai LifeSciences Holdings, Inc. $MRVI Acquired by Voleon Capital Management LP - MarketBeat
Growth Value: Is Maravai LifeSciences Holdings Incs ROIC above industry average2025 Breakouts & Breakdowns & Community Consensus Picks - خودرو بانک
Earnings Beat: What are Maravai LifeSciences Holdings Incs earnings expectations2025 Valuation Update & Weekly Sector Rotation Insights - خودرو بانک
Candlestick signals on Maravai LifeSciences Holdings Inc. stock todayEarnings Summary Report & Free Weekly Chart Analysis and Trade Guides - newser.com
Published on: 2025-09-14 04:51:10 - newser.com
Maravai Lifesciences Holdings Inc Stock (MRVI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.62%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):